Kallikrein 3/PSA ELISA DKK300 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemKallikrein 3/PSA ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $680.00Supplier Page View Company Product Page
Catalog NumberDKK300
Quantity1 Kit
ApplicationsELISA
Detection Range0.94 - 60 ng/mL
ReactivityHuman
Sample TypeCell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL)
Sensitivity0.069 ng/mL
Detection TargetKallikrein 3/PSA
Assay Time4.5 hours
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene Namekallikrein related peptidase 3
NCBI Gene AliasesAPS, KLK2A1, PSA, hK3

Specifications/Features

Available conjugates: Specificity: Natural and recombinant human KLK3/PSA

Sizes Available: 1 Kit

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Mechanistic Language Modeling and Oxygenated 3D Screening Reveal Berberine and Enzalutamide Synergy in Resistant Prostate CancerbioRxivJanuary 30, 2026Chih-Hui Lo, Katie Shi, Lina Kafadarian, Alexandra Bermudez, Johnny Diaz, Liam Edwards, Yunqi Hong, Ziyi Chen, Hyeonji Hwang, Weihong Yan, et al.concentrations were quantified using the Human Kallikrein 3/PSA Quantikine ELISA Kit (R&D Systems, Cat# DKK300) according to the manufacturer’s instructions. DNA from spheroids was extracted with the GeneJET Genomic

(2) Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer ModelsInternational journal of molecular sciencesDecember 21, 2024Hagemann UB, Schatz CA, Suominen MI, Schlicker A, Knuuttila M, Wilson T, Alhoniemi E, Käkönen SM, Haendler B, Scholz A.

(3) Insight into prostate cancer osteolytic metastasis by RelB coordination of IL‐8 and S100A4Clinical and Translational MedicineOctober 16, 2024Wenbo Sun, Kenny Xu, Xiao Li, Peipei Qian, Fan Xu, Yanyan Zhang, Xiumei Wang, Zhi Xu, Jiaji Ding, Xinyu Xu, et al.samples were spun at 3500 g to collect serum and stored at –80°C. ELISA kits were used to measure PSA (DKK300, R&D Systems), IL‐8 (D8000C, R&D Systems), and S100A4 (ab283547, Abcam) concentrations in the serum

(4) TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancerMolecular OncologyAugust 1, 2024Shohei Yoshida, Daisuke Kajiwara, Masanao Seki, Manabu Tayama, Yuki Tanaka, Hiroya Mizutani, Ryoto Fujita, Keisuke Yamamura, Shigeo Okajima, Masanori Asai, et al.Serum prostate‐specific antigen (PSA) concentrations were assessed using a PSA ELISA kit (Catalog #DKK300; R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions, and the data were

(5) Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptivesPLOS ONENovember 10, 2023Rushil Harryparsad, Bahiah Meyer, Ongeziwe Taku, Myrna Serrano, Pai Lien Chen, Xiaoming Gao, Anna-Lise Williamson, Celia Mehou-Loko, Florence Lefebvre d’Hellencourt, Jennifer Smit, et al.unprotected sex was measured using Human Kallikrein 3/PSA Quantikine ELISA (R&D Systems, US–catalog no. DKK300). Reagent preparation and assay procedures were conducted according to the manufacturer’s instructions.

(6) Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer ModelInternational journal of molecular sciencesJanuary 22, 2023Suominen MI, Knuuttila M, Schatz CA, Schlicker A, Vääräniemi J, Sjöholm B, Alhoniemi E, Haendler B, Mumberg D, Käkönen SM, et al.

(7) A phase I/ II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinomaInternational Journal of CancerNovember 1, 2022Jung Hyun Jo, Dawoon E. Jung, Hee Seung Lee, Soo Been Park, Moon Jae Chung, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Sangsook Cho, Si Young SongPDGFB (DBB00), TEK (or TIE2, DTE200), PECAM1 (DCD310), MMP2 (MMP200), pro‐MMP10 (DM1000), KLK3/PSA (DKK300), free IGFBP1 (DGB100), CX3CL1 (DCX310), IL19 (D1900) (all R&D SYSTEMS); and YAP (LifeSpan BioSciences,

(8) (+)-JJ-74-138 is a Novel Noncompetitive Androgen Receptor AntagonistMolecular cancer therapeuticsApril 1, 2022Cole RN, Chen W, Pascal LE, Nelson JB, Wipf P, Wang Z.was used to count the number of cells in each well. A human kallikrein 3/PSA Quantikine ELISA kit (DKK300, R&D systems, Minneapolis, MN) was then used according to the manufacturer’s protocol. PSA concentration

(9) Blocking GRP/GRP-R signaling decreases expression of androgen receptor splice variants and inhibits tumor growth in castration-resistant prostate cancerTranslational oncologyNovember 1, 2021Case TC, Merkel A, Ramirez-Solano M, Liu Q, Sterling JA, Jin R.

(10) Protein detection in blood with single-molecule imagingScience advancesAugust 1, 2021Mao CP, Wang SC, Su YP, Tseng SH, He L, Wu AA, Roden RBS, Xiao J, Hung CF.

(11) In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placentaElifeApril 8, 2019Maria Pernemalm, AnnSofi Sandberg, Yafeng Zhu, Jorrit Boekel, Davide Tamburro, Jochen M Schwenk, Albin Björk, Marie Wahren-Herlenius, Hanna Åmark, Claes-Göran Östenson, et al.diagnosed with metastatic prostate cancer (serving as positive controls) using ELISA kit R and D Systems #DKK300. PSA LC-MRM analysis Fraction 30–35 from the HiRIEF 4.0–4.25 strip from the optimization experiment

(12) In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placentaeLifeApril 8, 2019Maria Pernemalm et al.diagnosed with metastatic prostate cancer (serving as positive controls) using ELISA kit R and D Systems #DKK300. PSA LC-MRM analysis Fraction 30–35 from the HiRIEF 4.0–4.25 strip from the optimization experiment

(13) Tumor characterization by ultrasound-release of multiple protein and microRNA biomarkers, preclinical and clinical evidencePloS oneJanuary 1, 2018D'Souza AL, Chevillet JR, Ghanouni P, Yan X, Tewari M, Gambhir SS.PSA using ELISA kits from United Biotech, Inc. (CEA: CM-201; CA19-9: CM-801), R&D systems, Inc. (PSA: DKK300; endothelin-1: DET100; CA125: DCA125) and RayBiotech, Inc. (CA15-3: ELH-CA15-3). The standards of the

(14) Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse ModelsClinical cancer research : an official journal of the American Association for Cancer ResearchAugust 1, 2017Suominen MI, Fagerlund KM, Rissanen JP, Konkol YM, Morko JP, Peng Z, Alhoniemi EJ, Laine SK, Corey E, Mumberg D, et al.

(15) Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapyScientific reportsFebruary 1, 2017Sanna V, Singh CK, Jashari R, Adhami VM, Chamcheu JC, Rady I, Sechi M, Mukhtar H, Siddiqui IA.

(16) Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D₃) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyAmerican journal of clinical and experimental urologyJanuary 1, 2016Jarrard D, Konety B, Huang W, Downs T, Kolesar J, Kim KM, Havighurst T, Slaton J, House MG, Parnes HL, et al.

(17) Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancerBMC cancerOctober 2, 2014Eswaraka J, Giddabasappa A, Han G, Lalwani K, Eisele K, Feng Z, Affolter T, Christensen J, Li G.

(18) Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer TreatmentJournal of CancerJanuary 1, 2014Ivachtchenko AV, Mitkin OD, Kudan EV, Rjahovsky AA, Vorobiev AA, Trifelenkov AS, Shevkun NA, Proskurina OV, Kravchenko DV, Karapetian RN.Plasma was used to measure concentration of PSA (Quantikine; distributed by R&D Systems Inc.; Cat.#DKK300) and concentration of tested compounds. Statistical analyses were performed using GraphPad Prism. In

(19) Synergistic and tunable human gene activation by combinations of synthetic transcription factorsNature MethodsMarch 1, 2013Pablo Perez-Pinera, David G. Ousterout, Jonathan M. Brunger, Alicia M. Farin, Katherine A. Glass, Farshid Guilak, Gregory E. Crawford, Alexander J. Hartemink, Charles A. Gersbachenzyme-linked immunosorbent assay (ELISA), according to the manufacturer’s protocols (R&D Systems, Cat. No. DY280 and DKK300, respectively). For the IL-1Ra ELISA, the standard curve was prepared by diluting recombinant human

(20) Antitumor activity of a pyrrole-imidazole polyamideProceedings of the National Academy of Sciences of the United States of AmericaJanuary 29, 2013Yang F, Nickols NG, Li BC, Marinov GK, Said JW, Dervan PB.

Be the First to Write a Review!

Kallikrein 3/PSA ELISA

Kallikrein 3/PSA ELISA

Kallikrein 3/PSA ELISA

Kallikrein 3/PSA ELISA

Kallikrein 3/PSA ELISA from R&D Systems, a Bio-Techne Brand

Description

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (29)

Reviews

Kallikrein 3/PSA ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map